Difference between revisions of "Part:BBa K1699001:Design"
(→References) |
(→Design Notes) |
||
(One intermediate revision by the same user not shown) | |||
Line 7: | Line 7: | ||
===Design Notes=== | ===Design Notes=== | ||
− | Cloned into pSB1C3 using EcoRI and PstI | + | Designed using Benchling to meet registry standards. Synthesized by Syntezza Biosience. Cloned into pSB1C3 using EcoRI and PstI restriction sites. |
===Source=== | ===Source=== |
Latest revision as of 11:36, 13 September 2015
Human short TERT promoter
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Design Notes
Designed using Benchling to meet registry standards. Synthesized by Syntezza Biosience. Cloned into pSB1C3 using EcoRI and PstI restriction sites.
Source
Human genomic DNA sequence. Based on: Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers. Gu J, Kagawa S, Takakura M, Kyo S, Inoue M, Roth JA, Fang B. Cancer Res. 2000 Oct 1;60(19):5359-64. http://www.ncbi.nlm.nih.gov/pubmed/11034071